Products for Research Use Only
RegisterLogin

PA-9

CAT: 0804-HY-129421-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-129421-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
PA-9 is a pituitary adenylate cyclase-activating polypeptide (PACAP) type I (PAC1) receptor antagonist. PA-9 dose dependently inhibits PACAP-induced cAMP elevation with an IC50 of 5.6 nM. PA-9 can be used for the research of neuropathic and/or inflammatory pain[1].
CAS Number
1436004-46-4
UNSPSC
12352005
Hazard Statement
H315, H319, H335
Target
PACAP Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/pa-9.html
Purity
99.73
Solubility
DMSO : 250 mg/mL (ultrasonic)
Smiles
O=C(C(C1)CN(C2=NNC3=C2C=CC=C3)C1=O)NCCC4=CN=CN4
Molecular Formula
C17H18N6O2
Molecular Weight
338.36
Precautions
H315, H319, H335
References & Citations
[1]Takasaki I, et al. In Silico Screening Identified Novel Small-molecule Antagonists of PAC1 Receptor. J Pharmacol Exp Ther. 2018 Apr;365 (1) :1-8.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-149594CL-Pa
HY-112789-01(+) -JQ1 PA
HY-P10827-01PIC1 PA
HY-155684SA-PA
HY-10349517-PA
HY-133529-01PA-8
HY-147557-01PA-915
HY-P5981Chromozym t-PA
HY-101444A-01PAβN (dihydrochloride)
HY-133534PA-Nic (TFA)

Alternative Products

CatalogName
MBS5774336PA-9
HO016016-1K-01PA-PEG-PA, 1K
BLG-P112-01PA (2′,5′) pA
B7151-1017-PA
30R-3422PA Protein
T41005-01PA-8
T33857-01PA Autoinducer
256145-01PA 452
T79530-01SA-PA
A51899-100UGPA Antibody

Popular Products